Antibiotic Injection Recalled

Viatris Inc is recalling a single lot of ampicillin for injection following the report of a strand of hair in a vial, according to the October 5, 2022, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects ampicillin for injection in 2-gram vials (NDC 67457-352-02), 10 vials per carton (NDC 67457-352-10), from lot 7105130 (Exp. 9/23). The product was manufactured in India for Mylan Institutional, Rockford, IL, and distributed throughout the United States.

Viatris voluntarily initiated the recall September 21, 2022. On September 23, 2022, the FDA designated the recall Class II, signaling use of the product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.

Ampicillin for injection is a prescription antibiotic used in the treatment of certain respiratory tract infections, bacterial meningitis, septicemia and endocarditis, urinary tract infections, and gastrointestinal infections.